However, in KRAS-mutated pancreatic cancer, Li et al. described that TAP1 overexpression increased resistance to MEK inhibitors by facilitating drug transport out of cells and promoting cancer stemness48. The gene discussed is TAP1; the disease is pancreatic neoplasm.